Skip to main content

Bernie Sanders Criticizes Big Pharma Stock Buybacks Over Research Funding

Forbes Breaking NewsNovember 7, 20254 min918 views
4 connections·8 entities in this video→

Pharmaceutical Industry Priorities

  • πŸ’Š A significant concern raised is that 14 major pharmaceutical companies spent $87 billion more on stock buybacks and dividends than on research and development over a 10-year period.
  • πŸ’° CEOs of major drug companies reportedly earn over $100 million in compensation, raising questions about the industry's primary goals.

The Role of Shareholder Responsibility

  • πŸ“ˆ Pharmaceutical companies are primarily responsible to their shareholders, which influences their financial decisions.
  • πŸ’‘ It is suggested that stimulating innovation is most efficient when funding is directed to academic institutions where discoveries originate, rather than to large pharmaceutical companies.

Innovation Funding and Public Research

  • πŸ”¬ Pharmaceutical companies are spending only about 10-20% of their revenues on innovation.
  • πŸ’° Publicly funded research, such as through the NIH, is seen as a more effective way to incentivize innovation than direct funding to end-stage product developers.
  • 🎯 The goal should be financing research, not solely enriching stockholders or providing excessive CEO compensation.

Impact of High Drug Costs on Patients

  • ⚠️ One in four Americans cannot afford the prescription drugs their doctors prescribe.
  • πŸ’” The high cost of prescription drugs can be a matter of life and death for patients, forcing difficult choices between medication, rent, and other necessities.
  • πŸ₯ Delayed care due to unaffordability can lead to hospitalizations and, in some cases, death among patients.
Knowledge graph8 entities Β· 4 connections

How they connect

An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.

Hover Β· drag to explore
8 entities
Chapters1 moments

Key Moments

Transcript18 segments

Full Transcript

Topics12 themes

What’s Discussed

Big PharmaStock BuybacksResearch and DevelopmentPharmaceutical IndustryCEO CompensationShareholder ValueInnovationPublicly Funded ResearchNIHPrescription Drug CostsHealthcare AffordabilityPatient Outcomes
Smart Objects8 Β· 4 links
CompaniesΒ· 3
ConceptsΒ· 3
PeopleΒ· 2